JPRN-UMIN000049879招募中4 期
Efficacy, equivalence and operability of switching to a combination of budesonide, glycopyrronium, and formoterol in patients with COPD and ACO - Efficacy, equivalence and operability of switching to a combination of budesonide, glycopyrronium, and formoterol in patients with COPD and ACO
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Under 40 years old 2) Patients who have difficulty inhaling by theirself 3) Patients for whom the physician determines that pulmonary function testing is impossible or inaccurate for any reason (e.g., hearing loss, pregnancy, etc.) 4) Patients whose QoL or lung function may be affected during the study period, as determined by the physician: e.g., patients with end-stage cancer, severe heart failure, liver cirrhosis, respiratory failure, etc. 5) Patients who cannot use ICS or LABA or LAMA
研究者
相似试验
已完成
不适用
Investigation of efficacy and safety of switching from basal-bolus therapy to combination therapy with GLP-1 receptor agonist and basal insulin injection in type 2 diabetestype 2 diabetesJPRN-UMIN000013222Juntendo University Graduate School of Medicine30
尚未招募
3 期
B/F/TAF to DTG/3TC Switch StudyHIV/AIDSPACTR202404870570433niversity of Nairobi240
尚未招募
Unknown
Study of the effectiveness and safety of switching from JAK inhibitors to non-TNF biologics in elderly patients with rheumatoid arthritisRheumatoid arthritisJPRN-UMIN000050387Kawasaki Medical School30
已完成
不适用
Evaluation of the efficacy and safety for switching from premixed insulin to ultra-long acting insulin plus ultra-rapid insulitype 2 diabetesJPRN-UMIN000009562Department of Endocrinology and Metabolism, Nagoya City West Medical Center40
进行中（未招募）
1 期
Assessing the safety and efficacy of switching to Azarga (Brinzolamide/Timolol Fixed Combination), as replacement therapy in patients with uncontrolled intraocular pressure - not applicableEUCTR2009-015795-10-SIAlcon d.o.o.120